Literature DB >> 22718374

Selected clotting factors in blood of patients with abdominal aortic aneurysms.

Maria Kotschy1, Wojciech Witkiewicz, Ryszard Grendziak, Joanna Dubis, Norbert Zapotoczny, Daniel Kotschy.   

Abstract

BACKGROUND: Tissue factor (TF), tissue factor pathway inhibitor (TFPI) and vascular endothelial growth factor A (VEGF-A) present in vascular structures take part in blood coagulation and in organ revascularisation. The concentration of thrombin-antithrombin complexes (TAT) in blood of patients with abdominal aortic aneurysms (AAA) reflects thrombin-generation. AIM: To determine the concentration of TF, TFPI, VEGF-A and TAT complexes in blood of patients with AAA and to consider if these factors after clot formation can play a role in the pathogenesis of abdominal aortic aneurysms.
METHODS: Forty eight patients (43 men and 5 women) in the age of 59-80 (mean 72) years with AAA were examined. The blood was drawn in the morning to 3.2% natrium citrate in proportion 9:1. The concentration of TF, TFPI, VEGF-A and TAT complexes were measured in plasma with commercial kits using enzyme immunoassay.
RESULTS: In plasma of patients with AAA the mean concentration of TF was elevated almost twice and TAT complexes were three times higher compared with controls. But the mean levels of TFPI and VEGF-A were similar as in control group.
CONCLUSIONS: Increased concentrations of TF and TAT complexes indicate on high thrombin-generation, hypercoagulability and formation in abdominal aortic aneurysm of intraluminal thrombus, which can induce proteolytic processes in aortic wall.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718374

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  3 in total

1.  FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms.

Authors:  Guillermo Moñux; Jose J Zamorano-León; Pablo Marqués; Bernardo Sopeña; J M García-García; G Laich de Koller; Bibiana Calvo-Rico; Miguel A García-Fernandez; J Serrano; Antonio López-Farré
Journal:  Br J Clin Pharmacol       Date:  2017-08-27       Impact factor: 4.335

2.  Prognostic value of tissue factor in patients with abdominal aortic and iliac arterial aneurysms - preliminary study.

Authors:  Jan Skóra; Tomasz Dawiskiba; Patrycja Zaleska; Jacek Kurcz; Agnieszka Mastalerz-Migas; Rajmund Adamiec; Izabela Gosk-Bierska
Journal:  Arch Med Sci       Date:  2013-12-26       Impact factor: 3.318

3.  Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis.

Authors:  Corey S Moran; Sai-Wang Seto; Smriti M Krishna; Surabhi Sharma; Roby J Jose; Erik Biros; Yutang Wang; Susan K Morton; Jonathan Golledge
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.